Introduction:
Pyrimidine nucleotides are essential components of nucleic acids like DNA and RNA. The major pyrimidine nucleotides include:
- Cytidine monophosphate (CMP)
- Uridine monophosphate (UMP)
- Thymidine monophosphate (TMP)
Unlike purine nucleotide synthesis, in pyrimidine nucleotide metabolism the six-membered pyrimidine ring is synthesized first and then attached to a ribose phosphate group, which comes from phosphoribosyl pyrophosphate (PRPP).
Precursors for De Novo Synthesis of Pyrimidine Nucleotides:
The atoms that form the pyrimidine ring come from the following sources:
- Glutamine provides the nitrogen at position N3.
- Aspartic acid contributes carbon atoms C4, C5, C6, and nitrogen N1.
- Carbon dioxide (CO₂) contributes carbon at position C2.
Major Steps in De Novo Synthesis of Pyrimidine Nucleotides:
- Formation of carbamoyl phosphate: The first step involves combining glutamine, ATP, and CO₂ to form carbamoyl phosphate. This reaction is catalyzed by the enzyme carbamoyl phosphate synthase-II (CPS-II), located in the cytoplasm. Note that this is different from mitochondrial CPS-I, which participates in the urea cycle.
- Formation of carbamoyl aspartate: Carbamoyl phosphate combines with aspartate to form carbamoyl aspartate, catalyzed by aspartate transcarbamoylase. This is the committed step in pyrimidine biosynthesis.
- Cyclization to form dihydro-orotic acid: The enzyme dihydro-orotase removes water from carbamoyl aspartate, closing the ring structure to form dihydro-orotic acid.
- Oxidation to orotic acid: Dihydro-orotic acid is oxidized to orotic acid by dihydro-orotate dehydrogenase (a mitochondrial enzyme that requires NAD⁺). All other enzymes in this pathway are cytosolic.
- Attachment of ribose phosphate: The ribose phosphate group from PRPP is transferred to orotate to form orotidine monophosphate (OMP). This step is catalyzed by orotate phosphoribosyl transferase.
- Decarboxylation of OMP: OMP is decarboxylated to form uridine monophosphate (UMP).
- Formation of UDP and UTP: UMP is phosphorylated to UDP using ATP, and UDP is further phosphorylated to UTP by another kinase reaction.
- Formation of CTP: UTP is converted to cytidine triphosphate (CTP) by accepting an amino group from glutamine.
- Formation of deoxy forms: Ribonucleotide reductase converts UDP to dUDP.
- Formation of dUMP and dTMP: dUDP is dephosphorylated to dUMP. Then, thymidylate synthase catalyzes the methylation of dUMP using N⁵,N¹⁰-methylene tetrahydrofolate to produce deoxythymidine monophosphate (dTMP).
Regulation of De Novo Pyrimidine Nucleotide Synthesis:
The synthesis of pyrimidine nucleotides is tightly regulated to maintain balance between nucleotides. The first two enzymes — carbamoyl phosphate synthase-II (CPS-II) and aspartate transcarbamoylase — are key regulatory points and function through allosteric control mechanisms:
- Carbamoyl phosphate synthase-II (CPS-II): Inhibited by UTP (end product feedback inhibition) and activated by PRPP.
- Aspartate transcarbamoylase: Inhibited by CTP and activated by ATP.
This coordination ensures balanced production of pyrimidine nucleotides for DNA and RNA synthesis.
Catabolism of Pyrimidine Nucleotides:
Unlike purines, which are broken down into uric acid (a poorly soluble product), pyrimidine nucleotides degrade into water-soluble end products, making their breakdown more efficient.
End products of pyrimidine catabolism:
- Carbon dioxide (CO₂)
- Ammonia (NH₃)
- β-alanine
- β-aminoisobutyrate
In humans, β-aminoisobutyrate is transaminated to form methylmalonate semialdehyde, which is later converted to succinyl-CoA through methylmalonyl-CoA. Similarly, β-alanine can be converted into acetyl-CoA and used in energy metabolism.
Detailed Notes:
For PDF style full-color notes, open the complete study material below: